Definitive Healthcare Corp., an industry leader in healthcare commercial intelligence, has announced the pricing of its initial public offering of its Class A common stock. Definitive Healthcare is offering 15,555,555 shares of its Class A common stock at a price to the public of US$27.00 per share. The underwriters have a 30-day option to purchase up to an additional 2,333,333 shares of its Class A common stock at the initial public offering price, less underwriting discounts and commissions. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “DH” on September 15, 2021. The offering is expected to close on September 17, 2021, subject to the satisfaction of customary closing conditions.
Latham & Watkins LLP represents the underwriters in the offering with a capital markets team led by Chicago partners Cathy Birkeland and Alexa Berlin and New York partner Senet Bischoff, with Chicago associates Ben Winnett, Greer Gaddie, and Hane Kim. Advice was also provided on tax matters by Chicago partner Joseph Kronsoble, with Chicago associate Chris Ohlgart; on intellectual property matters by Bay Area partner Anthony Klein, with Bay Area associate Ryan Sanders; on benefits & executive compensation matters by New York counsel Rifka Singer, with New York associate Anne Bracaglia; and on data privacy & security matters by Bay Area counsel Heather Deixler, with Los Angeles associate Heather Lui.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.